Coherus BioSciences, Inc. (CHRS)
Latest CHRS Insider Trades
About Coherus BioSciences, Inc. (CHRS)
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
- REDWOOD CITY, CA
- 144
- 2014
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 29 | 4,055,000 | |
| Derivative transaction | 15 | 3,425,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
CHRS Insider Transactions (Form 4)
5114 Form 4 filings on record, the earliest from Dec 17, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ali J. Satvat | Grant or award | Common Stock | 30,000 | $0.00 |
Recent CHRS Form 8-K Filings
5CHRS Insider Trading - FAQ
What is the latest insider trade for CHRS?
Coherus BioSciences, Inc. (CHRS) had 9 insider filings in the last 90 days, with the most recent on 2026-06-10. The full record for CHRS runs to 14 Form 4 filings, the earliest from 2024-12-17. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CHRS stock?
No insider purchases of CHRS were filed in the last 90 days.
How many insiders are selling CHRS stock?
No insider sales of CHRS were filed in the last 90 days.
Where can I see CHRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks CHRS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CHRS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add CHRS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Ali J. Satvat view on EDGAR
- - Rita A. Karachun view on EDGAR
- - Lee Nisley Newcomer view on EDGAR
- - Michael Lee Ryan view on EDGAR
- - Jill O'Donnell-Tormey view on EDGAR
- - Mats Wahlstrom view on EDGAR
- - Charles W. Newton view on EDGAR
- - Bryan J. McMichael view on EDGAR
- - Dennis M. Lanfear view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track CHRS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
